|
|
Volumn 40, Issue , 2000, Pages 649-674
|
|
Dual protease inhibitor therapy in HIV-infected patients: Pharmacologic rationale and clinical benefits
|
|
Author keywords
Cytochrome P450; Drug interactions; P glycoprotein; Pharmacodynamics; Pharmacokinetics
|
|
Indexed keywords
AMPRENAVIR;
CD4 ANTIGEN;
CYTOCHROME P450;
GLUCURONOSYLTRANSFERASE;
GLYCOPROTEIN P;
INDINAVIR;
LAMIVUDINE;
LIPID;
LIVER ENZYME;
NELFINAVIR;
ORAL CONTRACEPTIVE AGENT;
OROSOMUCOID;
PROTEINASE INHIBITOR;
RITONAVIR;
SAQUINAVIR;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERBILIRUBINEMIA;
NEPHROLITHIASIS;
PARESTHESIA;
PRIORITY JOURNAL;
REVIEW;
VIRUS LOAD;
|
|
EID: 0034128937
PISSN: 03621642
EISSN: None
Source Type: Book Series
DOI: 10.1146/annurev.pharmtox.40.1.649 Document Type: Review |
|
Times cited : (99)
|
|
References (85)
|
